Back
SPDR® Kensho Final Frontiers ETF Vs. Spyre Therapeutics Industry Stock Comparison
Buy
52
ROKT
SPDR® Kensho Final Frontiers ETF
Last Price:
50.56
Seasonality Move:
5.91%
Buy
59
SYRE
Spyre Therapeutics
Last Price:
28.46
Seasonality Move:
-2.85%
Buy
52
SPDR® Kensho Final Frontiers ETF (ROKT)
is a Buy
Is SPDR® Kensho Final Frontiers ETF a Buy, Sell or Hold?
- The current SPDR® Kensho Final Frontiers ETF [ROKT] share price is $50.55. The Score for ROKT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- ROKT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Spyre Therapeutics (SYRE)
is a Buy
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $28.49. The Score for SYRE is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- SYRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ROKT Stock Price Chart
What is SPDR® Kensho Final Frontiers ETF's stock price today?
-
The SPDR® Kensho Final Frontiers ETF share price today is $50.55
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ROKT is experiencing slight selling pressure.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $28.49
The current trend is moderately bearish and SYRE is experiencing slight selling pressure.
ROKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.61 | Buy |
| Relative Strength Index (14 RSI): | 69.03 | Buy |
| Chaikin Money Flow: | -226 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.64 - 49.56) | Buy |
| Bollinger Bands (100): | (44.94 - 48.36) | Buy |
SYRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 50.42 | Buy |
| Chaikin Money Flow: | -266699 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.36 - 29.44) | Buy |
| Bollinger Bands (100): | (25.41 - 33.73) | Sell |
ROKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.54 | Buy |
| 20-day SMA: | 48.53 | Buy |
| 50-day SMA: | 48.04 | Buy |
| 200-day SMA: | 45.05 | Buy |
| 8-day EMA: | 49.59 | Buy |
| 20-day EMA: | 48.89 | Buy |
| 50-day EMA: | 47.98 | Buy |
| 200-day EMA: | 45.38 | Buy |
SYRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.1 | Sell |
| 20-day SMA: | 28.68 | Sell |
| 50-day SMA: | 27.86 | Buy |
| 200-day SMA: | 29.37 | Sell |
| 8-day EMA: | 28.79 | Sell |
| 20-day EMA: | 28.56 | Sell |
| 50-day EMA: | 28.37 | Buy |
| 200-day EMA: | 27.38 | Buy |
SPDR® Kensho Final Frontiers ETF Earnings Growth & ROKT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.24 per share, an increase this year of $9.51 per share, and an increase next year of $0.02 per share.
SPDR® Kensho Final Frontiers ETF Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Spyre Therapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||